(WH) Wyndham Hotels & Resorts - Ratings and Ratios
Hotel Franchising, Brand Licensing, Loyalty Program
Dividends
| Dividend Yield | 2.73% |
| Yield on Cost 5y | 3.76% |
| Yield CAGR 5y | 28.36% |
| Payout Consistency | 93.2% |
| Payout Ratio | 34.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.7% |
| Value at Risk 5%th | 37.8% |
| Relative Tail Risk | -10.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.82 |
| Alpha | -39.02 |
| CAGR/Max DD | 0.09 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.334 |
| Beta | 1.072 |
| Beta Downside | 1.105 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.17% |
| Mean DD | 11.06% |
| Median DD | 8.17% |
Description: WH Wyndham Hotels & Resorts November 05, 2025
Wyndham Hotels & Resorts, Inc. (NYSE: WH) is a global hotel franchisor that licenses a broad portfolio of mid-scale and upscale brands-including Super 8, Days Inn, Ramada, Wyndham Grand, and the Trademark Collection-to third-party owners, while also offering managed-service solutions and a guest loyalty program. The company, incorporated in 2017 and headquartered in Parsippany, New Jersey, generates revenue primarily from franchise fees, management fees, and loyalty-related earnings.
Key industry metrics that influence Wyndham’s performance are RevPAR (Revenue per Available Room) trends in the mid-scale segment, which have risen ~4% YoY in the U.S. as leisure travel rebounds, and the franchise-to-ownership conversion rate, currently hovering around 55%, indicating a steady pipeline of new franchisees. Additionally, macro-drivers such as the U.S. consumer confidence index and discretionary spending levels remain critical, as they directly affect occupancy rates for the brand’s price-sensitive properties.
For a deeper dive into Wyndham’s valuation assumptions and scenario analysis, you may find ValueRay’s detailed model a useful next step.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (338.0m TTM) > 0 and > 6% of Revenue (6% = 86.2m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 0.84pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 4.81% (prev -1.01%; Δ 5.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 349.0m > Net Income 338.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.56b) to EBITDA (653.0m) ratio: 3.92 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (76.9m) change vs 12m ago -2.90% (target <= -2.0% for YES) |
| Gross Margin 75.63% (prev 56.71%; Δ 18.92pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 33.79% (prev 33.37%; Δ 0.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.37 (EBITDA TTM 653.0m / Interest Expense TTM 135.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.87
| (A) 0.02 = (Total Current Assets 508.0m - Total Current Liabilities 439.0m) / Total Assets 4.35b |
| (B) 0.19 = Retained Earnings (Balance) 811.0m / Total Assets 4.35b |
| (C) 0.14 = EBIT TTM 590.0m / Avg Total Assets 4.25b |
| (D) 0.22 = Book Value of Equity 813.0m / Total Liabilities 3.76b |
| Total Rating: 1.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 64.57
| 1. Piotroski 4.50pt |
| 2. FCF Yield 3.66% |
| 3. FCF Margin 20.47% |
| 4. Debt/Equity 4.51 |
| 5. Debt/Ebitda 3.92 |
| 6. ROIC - WACC (= 6.82)% |
| 7. RoE 56.76% |
| 8. Rev. Trend -7.95% |
| 9. EPS Trend 51.30% |
What is the price of WH shares?
Over the past week, the price has changed by +0.07%, over one month by -0.48%, over three months by -13.72% and over the past year by -23.07%.
Is WH a buy, sell or hold?
- Strong Buy: 9
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the WH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 95.7 | 29.5% |
| Analysts Target Price | 95.7 | 29.5% |
| ValueRay Target Price | 69.4 | -6.1% |
WH Fundamental Data Overview November 26, 2025
P/E Trailing = 16.5358
P/E Forward = 14.5349
P/S = 3.8072
P/B = 9.4239
P/EG = 0.9314
Beta = 0.78
Revenue TTM = 1.44b USD
EBIT TTM = 590.0m USD
EBITDA TTM = 653.0m USD
Long Term Debt = 2.58b USD (from longTermDebt, last quarter)
Short Term Debt = 45.0m USD (from shortTermDebt, last quarter)
Debt = 2.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.56b USD (from netDebt column, last quarter)
Enterprise Value = 8.02b USD (5.47b + Debt 2.63b - CCE 70.0m)
Interest Coverage Ratio = 4.37 (Ebit TTM 590.0m / Interest Expense TTM 135.0m)
FCF Yield = 3.66% (FCF TTM 294.0m / Enterprise Value 8.02b)
FCF Margin = 20.47% (FCF TTM 294.0m / Revenue TTM 1.44b)
Net Margin = 23.54% (Net Income TTM 338.0m / Revenue TTM 1.44b)
Gross Margin = 75.63% ((Revenue TTM 1.44b - Cost of Revenue TTM 350.0m) / Revenue TTM)
Gross Margin QoQ = 92.41% (prev 59.19%)
Tobins Q-Ratio = 1.85 (Enterprise Value 8.02b / Total Assets 4.35b)
Interest Expense / Debt = 1.37% (Interest Expense 36.0m / Debt 2.63b)
Taxrate = 26.06% (37.0m / 142.0m)
NOPAT = 436.3m (EBIT 590.0m * (1 - 26.06%))
Current Ratio = 1.16 (Total Current Assets 508.0m / Total Current Liabilities 439.0m)
Debt / Equity = 4.51 (Debt 2.63b / totalStockholderEquity, last quarter 583.0m)
Debt / EBITDA = 3.92 (Net Debt 2.56b / EBITDA 653.0m)
Debt / FCF = 8.70 (Net Debt 2.56b / FCF TTM 294.0m)
Total Stockholder Equity = 595.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.78% (Net Income 338.0m / Total Assets 4.35b)
RoE = 56.76% (Net Income TTM 338.0m / Total Stockholder Equity 595.5m)
RoCE = 18.57% (EBIT 590.0m / Capital Employed (Equity 595.5m + L.T.Debt 2.58b))
RoIC = 13.88% (NOPAT 436.3m / Invested Capital 3.14b)
WACC = 7.06% (E(5.47b)/V(8.09b) * Re(9.96%) + D(2.63b)/V(8.09b) * Rd(1.37%) * (1-Tc(0.26)))
Discount Rate = 9.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.51%
[DCF Debug] Terminal Value 69.56% ; FCFE base≈274.8m ; Y1≈246.9m ; Y5≈211.5m
Fair Price DCF = 37.04 (DCF Value 2.80b / Shares Outstanding 75.6m; 5y FCF grow -12.57% → 3.0% )
EPS Correlation: 51.30 | EPS CAGR: 22.12% | SUE: 0.34 | # QB: 0
Revenue Correlation: -7.95 | Revenue CAGR: -0.69% | SUE: -1.87 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.93 | Chg30d=-0.057 | Revisions Net=-4 | Analysts=9
EPS next Year (2026-12-31): EPS=5.07 | Chg30d=-0.277 | Revisions Net=-13 | Growth EPS=+11.4% | Growth Revenue=+5.7%
Additional Sources for WH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle